Typhoid fever
Typhoid fever is a potentially life-threatening infection caused by Salmonella Typhi bacteria. It spreads mainly when people swallow food or water contaminated by human waste. Humans are its only known reservoir. People can continue passing the bacteria in their stools after they feel better, so recovery from symptoms does not always mean the infection has cleared. Symptoms usually start 1–3 weeks after exposure. They include prolonged fever, tiredness, headache, abdominal pain, and constipation or diarrhoea. Severe illness can cause serious complications, including holes in the intestine. Antibiotics can treat typhoid, but resistance makes some infections harder to treat. Extensively drug-resistant, or XDR, typhoid resists several important antibiotic groups; it is not a separate disease. Vaccines are available, including conjugate vaccines suitable for young children. Safe drinking water, sanitation, handwashing and food hygiene remain essential. WHO's estimates for 2019 were about 9 million illnesses and 110,000 deaths annually worldwide. These are historical estimates, not a count for 2026.
Key facts
| Transmission | Mainly ingestion of food or water contaminated by infected people's faeces; WHO also describes contamination by urine. People without symptoms and people recovering from illness can carry and spread the bacteria. |
|---|---|
| Incubation | Usually 1–3 weeks after exposure, according to WHO's 2015 Uganda notice. |
| Case fatality | unknown; the retrieved sources do not establish separate treated and untreated case-fatality estimates. |
| Reproduction number | unknown |
| Vaccine | Available. WHO recommends typhoid conjugate vaccine from 6 months of age; adult upper age limits depend on the product. Older injectable and oral vaccines are also available. WHO reported two prequalified conjugate vaccines as of 2023-03. |
| Treatment | Antibiotics; widespread resistance can require more complicated and expensive treatment. Prescribed courses should be completed, and follow-up testing may be needed to check for continued carriage. |
| Reservoir | Humans only, including people carrying the bacteria without symptoms. |
| Endemic regions | Parts of WHO's African, Eastern Mediterranean, South-East Asia and Western Pacific Regions, especially communities lacking safe water and adequate sanitation. |
Transmission
Typhoid spreads mainly through contaminated food and drinking water. The bacteria come from infected humans, including people who have no symptoms. WHO describes transmission through food or drink contaminated by faeces or urine. After symptoms disappear, some people still carry the bacteria and shed them in their stools. This makes handwashing and food-handler hygiene important, even during recovery. Humans are the only reservoir described by WHO. Safe water, adequate sanitation and properly cooked food reduce opportunities for spread. People being treated should avoid preparing or serving food for others and ask their doctor about testing to confirm that the bacteria have cleared.
- Typhoid WHO
- Typhoid fever – Uganda WHO · 17 Mar 2015
Symptoms and severity
Symptoms usually develop 1–3 weeks after exposure, according to WHO's 2015 Uganda notice. Common symptoms are prolonged high fever, tiredness, headache, nausea and abdominal pain. Constipation or diarrhoea can occur, and some people develop a rash. Illness ranges from mild to severe and can be fatal. Serious intestinal complications are an important concern: WHO's 2023 report from the Republic of the Congo described unusually frequent surgery for intestinal perforation, meaning a hole in the intestine, during a suspected mixed outbreak. Blood testing can confirm typhoid. The retrieved sources do not provide reliable separate fatality estimates for treated and untreated illness; the mixed-outbreak death rate should not be used as a typhoid-specific estimate.
- Typhoid WHO
- Typhoid fever – Uganda WHO · 17 Mar 2015
- Suspected triple outbreak of typhoid fever, shigellosis and cholera – Congo WHO · 21 Sept 2023
Treatment and vaccines
Antibiotics can treat typhoid, but antibiotic resistance is common and can make treatment more complicated and expensive. Treatment decisions therefore need to account for resistance. People should complete the course prescribed by their clinician, even if they feel better, and discuss follow-up testing for continued carriage. Vaccination helps prevent disease. WHO recommends typhoid conjugate vaccine from 6 months of age, with adult age limits depending on the product. Older injectable and oral vaccines are also available but require repeat or booster doses. Trials in Nepal and Malawi and a study in Pakistan's XDR outbreak setting have examined conjugate vaccines. Vaccination should accompany safe water, sanitation and food hygiene, rather than replace them.
- Typhoid WHO
- Phase 3 Efficacy Analysis of a Typhoid Conjugate Vaccine Trial in Nepal. Europe PMC · 1 Dec 2019
- Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children. Europe PMC · 1 Sept 2021
- Effectiveness of typhoid conjugate vaccine against culture-confirmed Salmonella enterica serotype Typhi in an extensively drug-resistant outbreak setting of Hyderabad, Pakistan: a cohort study. Europe PMC · 1 Aug 2021
Where it occurs
Typhoid remains a public-health problem in parts of WHO's African, Eastern Mediterranean, South-East Asia and Western Pacific Regions. Risk is higher where people lack safe drinking water and adequate sanitation, and WHO identifies children as the highest-risk group. Improved living conditions and antibiotics greatly reduced illness and deaths in industrialized countries, but travel can bring infections across borders. WHO documented travel-associated XDR infections linked to Pakistan in 2018. Its global estimates for 2019 were about 9 million illnesses and 110,000 deaths each year. These estimates describe the worldwide burden, not the number of cases in the site's archive or the current situation in Senegal.
- Typhoid WHO
- Typhoid fever – Pakistan WHO · 27 Dec 2018
Recent history
Open Outbreak's supplied archive contains eight typhoid events, and its history results span 1996–2018. The site also lists “Typhoid fever in Senegal” for monitoring; no supporting Senegal outbreak details were returned in this session. WHO's 2018-12-27 Pakistan notice reported 5,274 XDR cases among 8,188 typhoid cases in Sindh from 2016-11-01 through 2018-12-09. WHO assessed national XDR risk as high at that time. Its 2023-09-21 Congo notice described a suspected mixed outbreak involving typhoid, shigellosis and cholera. By 2023-08-29, there were 2,389 suspected cases and 52 deaths overall, with 22 Salmonella Typhi cases identified by laboratory analysis. Those totals are not typhoid-only counts. Retrieved notices do not establish the situation on 2026-11-22.
- 1996 - Typhoid fever in Algeria WHO Disease Outbreak News · 22 Jan 1996
- Typhoid fever – Pakistan WHO Disease Outbreak News · 27 Dec 2018
- Typhoid fever – Pakistan WHO · 27 Dec 2018
- Suspected triple outbreak of typhoid fever, shigellosis and cholera – Congo WHO · 21 Sept 2023
What to watch
Important warning signals include sustained outbreaks in new regions, infections associated with travel, and increasing resistance to antibiotics that still work locally. Human-to-human spread through contaminated food or water already occurs; the concern is evidence of expanding local transmission, not its first appearance. Rising numbers of intestinal complications or overwhelmed health facilities also warrant attention. WHO's Pakistan assessment highlighted unsafe water, poor sanitation, low vaccination coverage and limited surveillance as risk factors. Vaccine availability and delivery gaps matter because they can leave high-risk communities unprotected. Laboratory confirmation and antibiotic-resistance testing are especially valuable: suspected cases in a mixed outbreak should not all be labelled typhoid, and treatment failures require careful assessment.
- Typhoid fever – Pakistan WHO · 27 Dec 2018
- Suspected triple outbreak of typhoid fever, shigellosis and cholera – Congo WHO · 21 Sept 2023
- Typhoid WHO
- The international and intercontinental spread and expansion of antimicrobial-resistant Salmonella Typhi: a genomic epidemiology study. Europe PMC · 21 Jun 2022
Related outbreaks
- Typhoid fever in Senegal elevated